Thrivent Financial For Lutherans Bio Rad Laboratories, Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 4,498 shares of BIO stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,498
Previous 823 446.54%
Holding current value
$1.5 Million
Previous $225,000 568.89%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$263.97 - $344.64 $970,089 - $1.27 Million
3,675 Added 446.54%
4,498 $1.51 Million
Q2 2024

Aug 13, 2024
SELL
$268.26 - $339.48 $733,691 - $928,477
-2,735 Reduced 76.87%
823 $225,000
Q1 2024

May 14, 2024
SELL
$304.11 - $351.99 $4,865 - $5,631
-16 Reduced 0.45%
3,558 $1.23 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $66,265 - $89,799
-246 Reduced 6.44%
3,574 $1.15 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $2.71 Million - $3.27 Million
-7,747 Reduced 66.98%
3,820 $1.37 Million
Q2 2023

Aug 14, 2023
BUY
$359.49 - $486.4 $2.8 Million - $3.78 Million
7,777 Added 205.2%
11,567 $4.39 Million
Q1 2023

May 17, 2023
BUY
$418.69 - $503.0 $837 - $1,006
2 Added 0.05%
3,790 $1.82 Million
Q4 2022

Feb 08, 2023
SELL
$351.71 - $456.01 $1.32 Million - $1.71 Million
-3,741 Reduced 49.69%
3,788 $1.59 Million
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $1,650 - $2,253
-4 Reduced 0.05%
7,529 $3.14 Million
Q2 2022

Aug 16, 2022
SELL
$463.67 - $597.16 $786,847 - $1.01 Million
-1,697 Reduced 18.39%
7,533 $3.73 Million
Q1 2022

May 13, 2022
BUY
$524.57 - $735.42 $2.01 Million - $2.82 Million
3,835 Added 71.08%
9,230 $5.2 Million
Q4 2021

Feb 16, 2022
SELL
$708.84 - $794.68 $304,801 - $341,712
-430 Reduced 7.38%
5,395 $4.08 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $11,838 - $14,863
-18 Reduced 0.31%
5,825 $4.35 Million
Q2 2021

Aug 19, 2021
BUY
$576.64 - $649.04 $1,153 - $1,298
2 Added 0.03%
5,843 $3.77 Million
Q1 2021

May 17, 2021
SELL
$547.01 - $662.35 $351,727 - $425,891
-643 Reduced 9.92%
5,841 $3.34 Million
Q4 2020

Feb 16, 2021
SELL
$510.68 - $643.45 $6.72 Million - $8.46 Million
-13,152 Reduced 66.98%
6,484 $3.78 Million
Q3 2020

Nov 10, 2020
BUY
$454.43 - $535.6 $1.24 Million - $1.46 Million
2,728 Added 16.13%
19,636 $10.1 Million
Q2 2020

Aug 12, 2020
SELL
$334.87 - $493.06 $7.83 Million - $11.5 Million
-23,391 Reduced 58.04%
16,908 $7.63 Million
Q1 2020

May 15, 2020
SELL
$320.01 - $409.07 $9.16 Million - $11.7 Million
-28,612 Reduced 41.52%
40,299 $14.1 Million
Q4 2019

Feb 13, 2020
BUY
$319.73 - $374.2 $15 Million - $17.6 Million
46,927 Added 213.46%
68,911 $25.5 Million
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $2.89 Million - $3.28 Million
9,496 Added 76.04%
21,984 $7.32 Million
Q2 2019

Aug 13, 2019
BUY
$286.93 - $312.59 $24,675 - $26,882
86 Added 0.69%
12,488 $3.9 Million
Q1 2019

May 14, 2019
BUY
$224.3 - $317.41 $1.64 Million - $2.32 Million
7,313 Added 143.7%
12,402 $3.79 Million
Q4 2018

Feb 15, 2019
BUY
$220.1 - $309.0 $48,642 - $68,289
221 Added 4.54%
5,089 $1.18 Million
Q3 2018

Nov 15, 2018
BUY
$289.28 - $326.15 $73,187 - $82,515
253 Added 5.48%
4,868 $1.52 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $8,543 - $10,635
35 Added 0.76%
4,615 $1.33 Million
Q1 2018

May 08, 2018
BUY
$233.97 - $274.11 $37,903 - $44,405
162 Added 3.67%
4,580 $1.15 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $32,107 - $40,152
148 Added 3.47%
4,418 $1.05 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $906,392 - $1.03 Million
4,270
4,270 $949,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email